started · updated
Medical researchers announce breakthroughs in cancer and blood disease treatments
Medical researchers have unveiled several advancements in treating cancer and chronic blood disorders. A team led by Karl Landsteiner Private University discovered a molecular signal that, when blocked, allows natural killer cells to more effectively combat certain blood neoplasias, such as myeloproliferative neoplasms.
In leukemia research, scientists from the University Hospital Freiburg and Harvard University introduced the concept of “Dynamic Synthetic Lethality.” This approach targets chemotherapy-resistant cancer cells by using a second, timed treatment to exploit metabolic vulnerabilities created when cells attempt to survive initial therapy.
Additional studies are exploring the role of senescent cells in aging and disease. Researchers at the Memorial Sloan Kettering Cancer Center have tested nanoparticles designed to selectively eliminate these cells in fibrotic lung and liver tissue. Furthermore, new research published in Cell Metabolism suggests that the protein PD-L2 may act as an immune checkpoint that allows aged cells to evade the immune system, potentially contributing to age-related metabolic disorders.
Entities
Cell Metabolism · Friedrich-Alexander-Universität Erlangen-Nürnberg · Harvard University · Karl Landsteiner Privatuniversität · Memorial Sloan Kettering Cancer Center · University Hospital Freiburg · University Medical Center Freiburg